相关实验视频

Updated: Apr 28, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.6K

阳性HPVHNSCC和Fc静态PD-1封锁:一个临床差异,引发了下一个免疫问题

Kohei Okuyama1,2, Junya Fujimoto3,4,5, Souichi Yanamoto6

  • 1Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA KOkuyama@mdanderson.org.

Journal for immunotherapy of cancer
|August 31, 2025
PubMed
概括

在头部和部癌症中,Fc静态抗PD-1疗法表现有前途,但在HPV阳性病例中却意外失败. 这表明Fc受体相互作用可能对病毒性癌症的抗瘤免疫至关重要.

关键词:
生物标志物头部和部癌症免疫检查点抑制剂病毒特异性T细胞

更多相关视频

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.7K
Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

5.8K

相关概念视频

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K